Search:
Tokushima UniversityUniversity HospitalClinical DivisionDepartment of Internal MedicineRespiratory and Rheumatology Medicine
Tokushima UniversityFaculty of MedicineSchool of MedicineCourse of Bioregulation and Medical OncologyRespiratory Medicine and Rheumatology
(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

1. Hiroshi Nokihara, Hirokazu Ogino, Atsushi Mitsuhashi, Kensuke Kondo, Ei Ogawa, Ryohiko Ozaki, Yohei Yabuki, Hiroto Yoneda, Kenji Otsuka and Yasuhiko Nishioka :
Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion.,
BMC Cancer, Vol.22, No.1, 2022.
(Tokushima University Institutional Repository: 117282,   DOI: 10.1186/s12885-022-09701-2,   PubMed: 35650550)
2. Yutaka Morita, Atsuro Saijo, Hiroshi Nokihara, Atsushi Mitsuhashi, Hiroto Yoneda, Kenji Otsuka, Hirokazu Ogino, Yoshimi Bando and Yasuhiko Nishioka :
Radiation therapy induces an abscopal effect and upregulates programmed death-ligand 1 expression in a patient with non-small cell lung cancer.,
Thoracic Cancer, Vol.13, No.7, 1079-1082, 2022.
(Tokushima University Institutional Repository: 117392,   DOI: 10.1111/1759-7714.14330,   PubMed: 35064748)
3. Masahiro Sako, Hiroshi Nokihara, Kensuke Kondo, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Akane Abe, Hiroto Yoneda, Hirokazu Ogino, Kenji Otsuka, Hisanori Uehara and Yasuhiko Nishioka :
A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab.,
Thoracic Cancer, Vol.13, No.1, 129-132, 2021.
(Tokushima University Institutional Repository: 117393,   DOI: 10.1111/1759-7714.14243,   PubMed: 34859591)
4. Hiroto Yoneda, Hiroshi Nokihara, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Hirokazu Ogino, Kenji Otsuka and Yasuhiko Nishioka :
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma.,
BMC Pulmonary Medicine, Vol.21, No.1, 2021.
(Tokushima University Institutional Repository: 117283,   DOI: 10.1186/s12890-021-01746-6,   PubMed: 34781910)
5. Atsushi Mitsuhashi, Kensuke Kondoh, Kazuki Horikawa, Kazuya Koyama, Thi Na Nguyen, Tania Afroj, Hiroto Yoneda, Kenji Otsuka, Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara and Yasuhiko Nishioka :
Programmed death (PD)-1/PD-ligand 1 blockade mediates antiangiogenic effects by tumor-derived CXCL10/11 as a potential predictive biomarker.,
Cancer Science, Vol.112, No.12, 4853-4866, 2021.
(Tokushima University Institutional Repository: 117305,   DOI: 10.1111/cas.15161,   PubMed: 34628702)
6. Keiko Haji, Seidai Satou, Hiroto Yoneda, Toshihiko Nisisho, Hiroshi Nokihara and Yasuhiko Nishioka :
Multidisciplinary treatment of skeletal muscle metastasis from lung cancer: A case of triceps muscle metastasis of lung squamous cell cancer.,
Respiratory Medicine Case Reports, Vol.33, 2021.
(Tokushima University Institutional Repository: 117385,   DOI: 10.1016/j.rmcr.2021.101470,   PubMed: 34401306)
7. Tania Afroj, Atsushi Mitsuhashi, Hirokazu Ogino, Atsuro Saijo, Kenji Otsuka, Hiroto Yoneda, Makoto Tobiume, Thi Na Nguyen, Hisatsugu Goto, Kazuya Koyama, Masamichi Sugimoto, Osamu Kondoh, Hiroshi Nokihara and Yasuhiko Nishioka :
Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.,
The Journal of Immunology, Vol.206, No.6, 1204-1214, 2021.
(Tokushima University Institutional Repository: 115981,   DOI: 10.4049/jimmunol.2000909,   PubMed: 33504617)
8. Kenji Otsuka, Atsushi Mitsuhashi, Hisatsugu Goto, Masaki Hanibuchi, Kazuya Koyama, Hirohisa Ogawa, Hirokazu Ogino, Atsuro Saijo, Hiroyuki Kozai, Hiroto Yoneda, Makoto Tobiume, Masatoshi Kishuku, Keisuke Ishizawa and Yasuhiko Nishioka :
Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells.,
Lung Cancer, Vol.146, 86-96, 2020.
(Tokushima University Institutional Repository: 115324,   DOI: 10.1016/j.lungcan.2020.05.023,   PubMed: 32526602)
9. Akihiro Yoshimura, Tadaaki Yamada, Yusuke Okuma, Rui Kitadai, Takayuki Takeda, Takanori Kanematsu, Hisatsugu Goto, Hiroto Yoneda, Taishi Harada, Yutaka Kubota, Takahiro Yamada, Koji Date, Shinsuke Shiotsu, Kazuhiro Nagata, Yusuke Chihara, Yoshiko Kaneko, Junji Uchino, Yasuhiko Nishioka and Koichi Takayama :
Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients.,
Translational Lung Cancer Research, Vol.8, No.4, 450-460, 2019.
(Tokushima University Institutional Repository: 116474,   DOI: 10.21037/tlcr.2019.08.07,   PubMed: 31555518)
10. Masaki Hanibuchi, Akira Kanoh, Takuya Kuramoto, Tatsuro Saito, Makoto Tobiume, Atsuro Saijo, Hiroyuki Kozai, Mayo Kondou, Shun Morizumi, Hiroto Yoneda, Kozo Kagawa, Hirokazu Ogino, Seidai Satou, Hiroshi Kawano, Kenji Otsuka, Yuko Toyoda, Hiroshi Nokihara, Hisatsugu Goto and Yasuhiko Nishioka :
Development, validation, and comparison of gene analysis methods for detecting mutation from non-small cell lung cancer patients-derived circulating free DNA.,
Oncotarget, Vol.10, No.38, 3654-3666, 2019.
(Tokushima University Institutional Repository: 115668,   DOI: 10.18632/oncotarget.26951,   PubMed: 31217900)

Proceeding of International Conference:

1. Nguyen Na Thi, Atsushi Mitsuhashi, Hirokazu Ogino, Hiroyuki Kozai, Hiroto Yoneda, Afroj Tania, Kenji Otsuka, Hiroshi Nokihara and Yasuhiko Nishioka :
S-1 reduces myeloid-derived suppressor cells in murine mesothelioma model and enhances the anti-tumor activity of anti-PD-1 antibody,
APSR 2021, Kyoto and online, Nov. 2021.
2. Ryohiko Ozaki, Hiroshi Nokihara, Atsushi Mitsuhashi, Kondou Kensuke, YABUKI Yohhei, Hiroto Yoneda, Hirokazu Ogino, Kenji Otsuka and Yasuhiko Nishioka :
The clinical efficacy and safety of the second-line chemotherapy in extensive-disease small cell lung cancer patients with interstitial lung disease,
APSR 2021, Kyoto and online, Nov. 2021.
3. Hiroto Yoneda, Hiroshi Nokihara, Atsushi Mitsuhashi, Ryohiko Ozaki, YABUKI Yohhei, Hirokazu Ogino, Kenji Otsuka and Yasuhiko Nishioka :
Association of immune-related adverse events with therapeutic response to Nivolumab in patients with malignant pleural mesothelioma,
APSR 2021, Kyoto and online, Nov. 2021.
4. Hirokazu Ogino, Afroj Tania, Atsushi Mitsuhashi, Atsuro Saijo, Kenji Otsuka, Hiroto Yoneda, Nguyen Thi Na, Kozo Kagawa, Sugimoto Masamichi, Kondoh Osamu, Hiroshi Nokihara and Yasuhiko Nishioka :
Antigen-presenting capacity of fibrocytes and its regulation by anti-PD-1/PD-L1 antibodies,
APSR 2021, Kyoto and online, Nov. 2021.
5. Atsushi Mitsuhashi, Afroj Tania, Atsuro Saijo, Kenji Otsuka, Hiroto Yoneda, Kazuya Koyama, Sugimoto Masamichi, Kondoh Osamu, Hiroshi Nokihara and Yasuhiko Nishioka :
The role of fibrocyte-like cells in combination treatment of immune checkpoint inhibitor with antiangiogenic agents,
ERS International Congress 2020 Virtual, WEB, Sep. 2020.
(DOI: 10.1183/13993003.congress-2020.1134)

Proceeding of Domestic Conference:

1. Ryohiko Ozaki, Hiroshi Nokihara, YABUKI Yohhei, Atsushi Mitsuhashi, Hiroto Yoneda, Kenji Otsuka, Hirokazu Ogino and Yasuhiko Nishioka :
Second-line chemotherapy for extensive-disease small cell lung cancer with interstitial lung disease,
第19回日本臨床腫瘍学会学術集会, Feb. 2022.
2. 市原 聖也, YABUKI Yohhei, Kohjin Murakami, Kozo Kagawa, Hiroto Yoneda, Hirokazu Ogino, Seidai Satou, Hiroshi Kawano, Hiroshi Nokihara and Yasuhiko Nishioka :
亜急性に進行し,蜂巣肺様の所見を呈した薬剤性肺障害の1例,
第125回日本内科学会四国地方会, Dec. 2021.
3. Atsushi Mitsuhashi, Hirokazu Ogino, Hiroto Yoneda, Kenji Otsuka, Hiroshi Nokihara and Yasuhiko Nishioka :
抗PD-1/PD-L1抗体による血管新生制御メカニズムの解析と治療効果予測バイオマーカーとしての応用,
第62回日本肺癌学会学術集会, Nov. 2021.
4. Ryohiko Ozaki, Hiroshi Nokihara, Atsushi Mitsuhashi, 近藤 健介, YABUKI Yohhei, Hiroto Yoneda, Hirokazu Ogino, Kenji Otsuka and Yasuhiko Nishioka :
間質性肺炎合併小細胞肺癌に対する二次化学療法の有効性及び安全性の検討,
第62回日本肺癌学会学術集会, Nov. 2021.
5. Hiroto Yoneda, Hiroshi Nokihara, Atsushi Mitsuhashi, Ryohiko Ozaki, YABUKI Yohhei, Hirokazu Ogino, Kenji Otsuka and Yasuhiko Nishioka :
悪性胸膜中皮腫患者におけるニボルマブの免疫関連有害事象と治療効果の相関性,
第59回日本癌治療学会学術集会, Oct. 2021.
6. Kenji Otsuka, Atsushi Mitsuhashi, Ryohiko Ozaki, YABUKI Yohhei, Hiroto Yoneda, Hirokazu Ogino, Hiroshi Nokihara, 竹内 栄治, 杉浦 八十生, 知花 賢治, 田村 厚久, 安宅 信二 and Yasuhiko Nishioka :
進展型小細胞肺癌における予後規定因子,
第59回日本癌治療学会学術集会, Oct. 2021.
7. 花房 翠, YABUKI Yohhei, Takeshi Imakura, Hiroto Yoneda, Akane Abe, 美馬 正人, Yuya Yamashita, Nobuhito Naito, Kozo Kagawa, Kenji Otsuka, Seidai Satou, Hiroshi Nokihara and Yasuhiko Nishioka :
ステロイドパルス療法後に増悪し二度目のパルス療法が奏効したCOVID-19肺炎の1例,
第63回日本呼吸器学会中国・四国地方会, Aug. 2021.
8. Satoshi Sakaguchi, YABUKI Yohhei, Takeshi Imakura, Hiroto Yoneda, Kohjin Murakami, Kazuya Koyama, Kozo Kagawa, 小川 瑛, Hirokazu Ogino, Seidai Satou, Hiroshi Kawano, Hiroshi Nokihara and Yasuhiko Nishioka :
索状の小葉間隔壁の肥厚を認め胸腔鏡下肺生検にて診断した間質性肺炎の1例,
第63回日本呼吸器学会中国・四国地方会, Aug. 2021.
9. 中内 友合江, YABUKI Yohhei, Keiko Haji, Hiroto Yoneda, Atsushi Mitsuhashi, 青井 優, 石田 卓也, 村上 尚哉, Hirokazu Ogino, Seidai Satou, Hiroshi Nokihara and Yasuhiko Nishioka :
Tepotinibが著効したMET遺伝子exon14 skipping変異陽性肺腺癌の1例,
第59回日本肺癌学会中国・四国支部学術集会, Aug. 2021.
10. 市原 聖也, YABUKI Yohhei, Ryohiko Ozaki, 近藤 健介, Hiroto Yoneda, Kenji Otsuka, Asami Fukuya, 高丸 利加子, 原田 祥子, Hirokazu Ogino, Seidai Satou, Hiroshi Nokihara and Yasuhiko Nishioka :
AtezolizumabのImmune-Related Adverse Eventによる急性腎障害を認めた非小細胞肺癌の1例,
第59回日本肺癌学会中国・四国支部学術集会, Aug. 2021.
11. Atsushi Mitsuhashi, Hirokazu Ogino, Hiroto Yoneda, Kenji Otsuka, Hiroshi Nokihara and Yasuhiko Nishioka :
肺がん肝転移におけるspheroid形成がん幹細胞様分画の役割,
第30回日本がん転移学会学術集会・総会, Jul. 2021.
12. Atsushi Mitsuhashi, Tania Afroj, Na Thi Nguyen, Hirokazu Ogino, Hiroto Yoneda, Kenji Otsuka, Hiroshi Nokihara and Yasuhiko Nishioka :
抗PD-1/PD-L1抗体による腫瘍血管新生抑制メカニズムの解析と治療効果予測バイオマーカーとしての応用.,
第25回日本がん分子標的治療学会学術集会, May 2021.
13. Na Thi Nguyen, Atsushi Mitsuhashi, Hiroyuki Kozai, Hiroto Yoneda, Afroj Tania, Kenji Otsuka, Hiroshi Nokihara and Yasuhiko Nishioka :
TS-1による腫瘍関連骨髄由来抑制細胞の制御を介した免疫チェックポイント阻害剤との併用効果の検討,
第25回日本がん分子標的治療学会学術集会, May 2021.
14. 近藤 健介, Hiroshi Nokihara, Seidai Satou, Atsushi Mitsuhashi, Hiroto Yoneda, Hiroyuki Kozai, Kenji Otsuka and Yasuhiko Nishioka :
非小細胞肺癌に対する免疫チェックポイント阻害剤の予後予測因子の検討,
第61回日本呼吸器学会学術講演会, Apr. 2021.
15. Hiroyuki Kozai, Atsushi Mitsuhashi, Ryohiko Ozaki, Hiroto Yoneda, Kenji Otsuka, Hiroshi Nokihara and Yasuhiko Nishioka :
免疫原性細胞死を誘導する細胞傷害性抗癌剤についての検討,
第61回日本呼吸器学会学術講演会, Apr. 2021.
16. 今倉 健, Nobuhito Naito, Yuya Yamashita, 原田 紗希, Kozo Kagawa, Hiroto Yoneda, Seidai Satou, Hiroshi Kawano, 長谷 加容子, Hiroshi Nokihara and Yasuhiko Nishioka :
当科における成人発症スティル病症例の検討,
第262回徳島医学会学術集会, Mar. 2021.
17. 尾崎 領彦, Atsushi Mitsuhashi, Hiroto Yoneda, Kenji Otsuka, Hiroshi Nokihara, Yasuhiko Nishioka, 櫻田 巧 and Keisuke Ishizawa :
ペメトレキセド投与後の皮疹に対するデキサメタゾン予防投与の効果の検討,
第18回日本臨床腫瘍学会学術集会, Feb. 2021.
18. Hiroto Yoneda, Nobuhito Naito, Hiroyuki Kozai, Kenji Otsuka, Seidai Satou, Hiroshi Kawano, Hiroshi Nokihara, Masahiko Azuma and Yasuhiko Nishioka :
当科における悪性胸膜中皮腫に対するnivolumab投与症例の検討,
第123回日本内科学会四国地方会, Nov. 2020.
19. Atsushi Mitsuhashi, 櫻田 巧, Mitsuhiro Goda, Yoshito Zamami, Hiroto Yoneda, Kenji Otsuka, Hiroshi Nokihara, Keisuke Ishizawa and Yasuhiko Nishioka :
ペメトレキセド投与後の皮疹に対する低用量デキサメタゾン予防効果の検討,
第61回日本肺癌学会学術集会, Nov. 2020.
20. Kenji Otsuka, Atsushi Mitsuhashi, Hiroto Yoneda, Hiroshi Nokihara, 竹内 栄治, 知花 賢治, 安宅 信二, 田村 厚久 and Yasuhiko Nishioka :
進展型小細胞肺癌の予後規定因子の検討,
第61回日本肺癌学会学術集会, Nov. 2020.
21. 櫻田 巧, Atsushi Mitsuhashi, Hiroto Yoneda, Kenji Otsuka, Mitsuhiro Goda, Yoshito Zamami, Keisuke Ishizawa, Hiroshi Nokihara and Yasuhiko Nishioka :
ペメトレキセド投与後の皮疹に対する低用量のステロイド予防投与の前向き臨床試験,
第58回日本癌治療学会学術集会, Oct. 2020.
22. Hiroyuki Kozai, Atsushi Mitsuhashi, Hiroto Yoneda, Kenji Otsuka, Hiroshi Nokihara and Yasuhiko Nishioka :
細胞障害性抗がん剤による腫瘍免疫原性細胞死誘導能の検討,
第58回日本癌治療学会学術集会, Oct. 2020.
23. Atsuro Saijo, Hiroyuki Kozai, Hisatsugu Goto, Kenji Otsuka, Hiroto Yoneda, Atsushi Mitsuhashi and Yasuhiko Nishioka :
非小細胞肺がんに合併した悪性胸水に対する bevacizumab の有効性と耐性化機序の解析,
第24回日本がん分子標的治療学会学術集会, Oct. 2020.
24. NGUYEN NA THI, Atsushi Mitsuhashi, Tania Afroj, Hiroto Yoneda, Hiroyuki Kozai, Kenji Otsuka, Hiroshi Nokihara and Yasuhiko Nishioka :
マウス中皮腫細胞株皮下移植モデルにおける細胞障害性抗癌剤の腫瘍関連骨髄由来抑制細胞への影響,
第24回日本がん分子標的治療学会学術集会, Oct. 2020.
25. Tania Afroj, Hirokazu Ogino, Atsushi Mitsuhashi, Hiroto Yoneda, Hiroyuki Kozai, Kenji Otsuka, Hiroshi Nokihara, Masahiro Abe and Yasuhiko Nishioka :
腫瘍免疫における線維細胞の免疫調節機能の検討,
第24回日本がん分子標的治療学会学術集会, Oct. 2020.
26. 近藤 健介, Hiroshi Nokihara, Atsushi Mitsuhashi, Hiroto Yoneda, Hiroyuki Kozai, Kenji Otsuka and Yasuhiko Nishioka :
非小細胞肺癌における免疫チェックポイント阻害剤の予後予測因子の検討,
第24回日本がん分子標的治療学会学術集会, Oct. 2020.
27. Hiroto Yoneda, 吉村 彰紘, Hisatsugu Goto, Yasuhiko Nishioka and 山田 忠明 :
既治療非小細胞肺がんを対象としたドセタキセル+ラムシルマブ併用に関する多施設共同後方視的検討,
第24回日本がん分子標的治療学会学術集会, Oct. 2020.
28. Atsushi Mitsuhashi, Tania Afroj, Hirokazu Ogino, NGUYEN NA THI, Hiroto Yoneda, Hiroyuki Kozai, Kenji Otsuka, 杉本 正道, 根東 攝, Hiroshi Nokihara and Yasuhiko Nishioka :
免疫チェックポイント阻害薬および血管新生阻害薬併用療法における腫瘍内 fibrocyte-like cell の機能解析,
第24回日本がん分子標的治療学会学術集会, Oct. 2020.
29. Hiroyuki Kozai, Atsushi Mitsuhashi, NGUYEN NA THI, Tania Afroj, Hiroto Yoneda, Kenji Otsuka, Hiroshi Nokihara and Yasuhiko Nishioka :
肺癌において細胞障害性抗癌剤が免疫原性細胞死に与える影響についての検討,
第24回日本がん分子標的治療学会学術集会, Oct. 2020.
30. 谷 望未, 吉村 彰紘, 山田 忠明, 大熊 裕介, 北台 留衣, 竹田 隆之, Takanori Kanematsu, Hisatsugu Goto, Hiroto Yoneda, Yasuhiko Nishioka, 原田 大司, 山田 崇央, 伊達 紘二, 塩津 伸介, 永田 一洋, 千原 佑介, 内野 順治 and 髙山 浩一 :
既治療非小細胞肺がんを対象としたドセタキセル+ラムシルマブ併用に関する多施設共同後方視的検討,
第60回日本呼吸器学会学術講演会, Sep. 2020.
31. 岡本 悠里, Kozo Kagawa, Kenji Otsuka, 宮本 直輝, Mitsuteru Yoshida, Hiroto Yoneda, Yuko Toyoda, Masahiko Azuma and Yasuhiko Nishioka :
胸腔内に多発した石灰化線維性腫瘍の1例,
第121回日本内科学会四国地方会, Dec. 2019.
32. 石田 卓也, Kozo Kagawa, Hiroto Yoneda, Kenji Nishimura, 山本 遥平, Seidai Satou, Hiroshi Kawano, Hiroshi Nokihara and Yasuhiko Nishioka :
顕微鏡的多発血管炎の治療中に重症筋無力症クリーゼを発症した1例,
第121回日本内科学会四国地方会, Dec. 2019.
33. 磯村 祐太, Kozo Kagawa, Hiroto Yoneda, Hiroshi Nokihara, Kenji Otsuka, Seidai Satou, Makoto Tobiume, Hiroyuki Kozai, Satoshi Sakaguchi, Masahiko Azuma and Yasuhiko Nishioka :
当科における悪性胸膜中皮腫の2次治療の検討,
第62回日本呼吸器学会中国・四国地方会, Nov. 2019.
34. Kenji Otsuka, Hiroto Yoneda, Atsushi Mitsuhashi, Hirokazu Ogino, Hiroyuki Kozai, Makoto Tobiume, Hiroshi Nokihara and Yasuhiko Nishioka :
間質性肺炎合併非小細胞肺癌における2次化学療法の安全性と有効性の検討,
第57回日本癌治療学会学術集会, Oct. 2019.
35. 石田 卓也, Kozo Kagawa, Hiroto Yoneda, 坂東 紀子, Nobuhito Naito, Hirokazu Ogino, Seidai Satou, Hiroshi Kawano, Kenji Nishimura, 山本 遥平, Yuko Toyoda, Hiroshi Nokihara and Yasuhiko Nishioka :
顕微鏡的多発血管炎の治療中に重症筋無力症クリーゼを発症した1例,
第259回徳島医学会学術集会, Aug. 2019.
36. 近藤 健介, Atsuro Saijo, Kozo Kagawa, Kenji Otsuka, Seidai Satou, Hiroto Yoneda, Makoto Tobiume, Hisatsugu Goto, Hiroshi Nokihara and Yasuhiko Nishioka :
末梢血検査値を用いた非小細胞肺癌に対する免疫チェックポイント阻害剤の効果予測因子の検討,
第58回日本肺癌学会中国・四国支部学術集会, Jul. 2019.
37. 安宅 克博, Kozo Kagawa, Mayo Kondou, Seidai Satou, Hiroto Yoneda, Hirokazu Ogino, Makoto Tobiume, Hiroyuki Kozai, Kenji Otsuka, Seidai Satou, Hiroshi Nokihara and Yasuhiko Nishioka :
Nivolumab投与により腹水の著明な減少を認めた悪性胸膜中皮腫の1例,
第58回日本肺癌学会中国・四国支部学術集会, Jul. 2019.
38. 近藤 圭大, Kozo Kagawa, Mayo Kondou, Hirokazu Ogino, Makoto Tobiume, Hiroto Yoneda, Kenji Otsuka, Seidai Satou, Hiroshi Nokihara and Yasuhiko Nishioka :
当科における局所進行非小細胞肺癌患者に対する化学放射線療法後のDurvalumabによる治療の臨床的検討,
第58回日本肺癌学会中国・四国支部学術集会, Jul. 2019.
39. Kenji Otsuka, Hisatsugu Goto, Masaki Hanibuchi, Hirokazu Ogino, Atsuro Saijo, Hiroyuki Kozai, Hiroto Yoneda, Makoto Tobiume and Yasuhiko Nishioka :
化学療法は腫瘍内の骨髄由来抑制細胞を減少させることにより抗PD-1抗体の抗腫瘍効果を増強する,
第28回日本がん転移学会学術集会・総会, Jul. 2019.
40. 西村 春佳, Hiroto Yoneda, Kozo Kagawa, 小山 壱也, Makoto Tobiume, Hirokazu Ogino, Atsuro Saijo, 宮本 憲哉, 原田 紗希, 坂東 紀子, Yuko Toyoda and Yasuhiko Nishioka :
癌性リンパ管症の診断にBAL が有用であった多発すりガラス陰影を呈した肺腺癌の1 例,
第42回日本呼吸器内視鏡学会学術集会, Jul. 2019.
41. Hiroto Yoneda, 西村 春佳, Kozo Kagawa, Makoto Tobiume, Hirokazu Ogino, 小山 壱也, Atsuro Saijo, Yuko Toyoda and Yasuhiko Nishioka :
気管支鏡検査にて診断し得たリンパ脈管筋腫症の1 例,
第42回日本呼吸器内視鏡学会学術集会, Jul. 2019.
42. Afroj Tania, Hirokazu Ogino, Makoto Tobiume, Hiroto Yoneda, Kisyuku Masatoshi, Atsuro Saijo, Atsushi Mitsuhashi, Koyama Kazuya, Hisatsugu Goto and Yasuhiko Nishioka :
Analyses of immuno-modulatory function of fibrocytes in tumor immunity,
The 59th Annual Meeting of the Japanese Respiratory Society, Apr. 2019.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)